Alkeon Capital Management LLC Tricida, Inc. Transaction History

Alkeon Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$8.56 - $26.93 $6.93 Million - $21.8 Million	-809,400 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$21.21 - $31.55 $2.12 Million - $3.16 Million	100,000 Added 14.1%	809,400 $22.2 Million
Q3 2019 Nov 14, 2019	BUY	$29.87 - $42.22 $1.49 Million - $2.11 Million	50,000 Added 7.58%	709,400 $21.9 Million
Q2 2019 Aug 14, 2019	BUY	$31.16 - $39.46 $15 Million - $18.9 Million	480,000 Added 267.56%	659,400 $26 Million
Q1 2019 May 15, 2019	BUY	$19.96 - $38.62 $3.58 Million - $6.93 Million	179,400 New	179,400 $6.93 Million

30K

124K

46.5K

Ticker TCDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,668,900
Market Cap $557K
Description
Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company ...

Get notified when there are updates to the investment portfolio of Alkeon Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Alkeon Capital Management LLC with notifications on news.